<DOC>
	<DOCNO>NCT01166074</DOCNO>
	<brief_summary>This study retrospective chart review use subcutaneous IgG ( SCIG ) infants less two year old .</brief_summary>
	<brief_title>Retrospective Chart Review Subcutaneous IgG Use Infants</brief_title>
	<detailed_description />
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<criteria>Infants receive one dose IgG subcutaneous route age two year . Consent parent/guardian require institution/IRB . Infants protein lose condition lymphangiectasis , nephrosis , S/P cardiothoracic surgery require drainage tube 48 hr , protein lose enteropathy . Concomitant treatment plasma , blood product IGIV SCIG . Lack consent parent/guardian ( require Institution/IRB ) . Any condition treatment , opinion local investigator , would interfere obtain valid result subject .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>2 Years</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>